Company · CIK 0001609727 · SIC 2834 — Pharmaceutical Preparations
Synthorx, Inc. · THOR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 24, 2019 MForm 4 → | Jan 25, 4:33 pm EST | Laura ShawverPresident and CEO, Director | 25,000 | $0.63 | $15,750 | 25,000 | — | plan? |
| Dec 11, 2018 PForm 4 → | Dec 13, 6:37 pm EST | Peter A. ThompsonDirector, 10% Owner | 1,363,636 | $11.00 | $14,999,996 | 5,316,355 | +34.5% | plan? |
| Dec 11, 2018 CForm 4 → | Dec 13, 6:37 pm EST | Peter A. ThompsonDirector, 10% Owner | 3,952,719 | — | — | 3,952,719 | — | plan? |
| Dec 11, 2018 PForm 4 → | Dec 13, 6:36 pm EST | Tighe ReardonActing Chief Financial Officer | 545,455 | $11.00 | $6,000,005 | 1,682,086 | +48.0% | plan? |
| Dec 11, 2018 CForm 4 → | Dec 13, 6:36 pm EST | Tighe ReardonActing Chief Financial Officer | 1,136,631 | — | — | 1,136,631 | — | plan? |
| Dec 11, 2018 PForm 4 → | Dec 13, 6:35 pm EST | Jay LichterDirector, 10% Owner | 545,455 | $11.00 | $6,000,005 | 1,682,086 | +48.0% | plan? |
| Dec 11, 2018 CForm 4 → | Dec 13, 6:35 pm EST | Jay LichterDirector, 10% Owner | 5,698,190 | — | — | 1,136,631 | — | plan? |
| Dec 11, 2018 CForm 4 → | Dec 13, 6:33 pm EST | ORBIMED ADVISORS LLC +1Director, 10% Owner | 3,952,719 | — | — | 5,316,355 | — | plan? |
| Dec 11, 2018 PForm 4 → | Dec 13, 6:33 pm EST | ORBIMED ADVISORS LLC +1Director, 10% Owner | 1,363,636 | $11.00 | $14,999,996 | 1,363,636 | — | plan? |
| Dec 11, 2018 PForm 4 → | Dec 13, 6:31 pm EST | Peter KolchinskyDirector, 10% Owner | 4,545,455 | $11.00 | $50,000,005 | 9,724,598 | +87.8% | plan? |
| Dec 11, 2018 CForm 4 → | Dec 13, 6:31 pm EST | Peter KolchinskyDirector, 10% Owner | 5,179,143 | — | — | 5,179,143 | — | plan? |
| Dec 11, 2018 PForm 4 → | Dec 13, 6:30 pm EST | Avalon Ventures X, L.P. +110% Owner | 545,455 | $11.00 | $6,000,005 | 1,682,086 | +48.0% | plan? |
| Dec 11, 2018 CForm 4 → | Dec 13, 6:30 pm EST | Avalon Ventures X, L.P. +110% Owner | 5,698,190 | — | — | 1,136,631 | — | plan? |
| Dec 11, 2018 PForm 4 → | Dec 13, 6:30 pm EST | RA CAPITAL MANAGEMENT, LLC +110% Owner | 4,545,455 | $11.00 | $50,000,005 | 9,724,598 | +87.8% | plan? |
| Dec 11, 2018 CForm 4 → | Dec 13, 6:30 pm EST | RA CAPITAL MANAGEMENT, LLC +110% Owner | 5,179,143 | — | — | 5,179,143 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 24, 2019 MForm 4 → | Jan 25, 4:33 pm EST | Laura ShawverPresident and CEO, Director | 25,000 | — | — | 319,528 | — | |
| Dec 19, 2018 AForm 4 → | Dec 21, 4:07 pm EST | Andrew Kenneth William PowellDirector | 27,015 | — | — | 27,015 | — | |
| Dec 11, 2018 CForm 4 → | Dec 13, 6:37 pm EST | Peter A. ThompsonDirector, 10% Owner | 6,333,206 | — | — | 0 | — | |
| Dec 11, 2018 CForm 4 → | Dec 13, 6:36 pm EST | Tighe ReardonActing Chief Financial Officer | 1,821,156 | — | — | 0 | — | |
| Dec 11, 2018 CForm 4 → | Dec 13, 6:35 pm EST | Jay LichterDirector, 10% Owner | 9,129,869 | — | — | 0 | — | |
| Dec 11, 2018 CForm 4 → | Dec 13, 6:33 pm EST | ORBIMED ADVISORS LLC +1Director, 10% Owner | 6,333,206 | — | — | 0 | — | |
| Dec 11, 2018 CForm 4 → | Dec 13, 6:31 pm EST | Peter KolchinskyDirector, 10% Owner | 8,298,233 | — | — | 0 | — | |
| Dec 11, 2018 CForm 4 → | Dec 13, 6:30 pm EST | Avalon Ventures X, L.P. +110% Owner | 9,129,869 | — | — | 0 | — | |
| Dec 11, 2018 CForm 4 → | Dec 13, 6:30 pm EST | RA CAPITAL MANAGEMENT, LLC +110% Owner | 8,298,233 | — | — | 0 | — | |
| Dec 6, 2018 AForm 4 → | Dec 7, 5:40 pm EST | Floyd RomesbergDirector | 30,000 | — | — | 30,000 | — | |
| Dec 6, 2018 AForm 4 → | Dec 7, 5:39 pm EST | Peter A. ThompsonDirector, 10% Owner | 30,000 | — | — | 30,000 | — | |
| Dec 6, 2018 AForm 4 → | Dec 7, 5:38 pm EST | Jay LichterDirector, 10% Owner | 30,000 | — | — | 30,000 | — | |
| Dec 6, 2018 AForm 4 → | Dec 7, 5:37 pm EST | Tighe ReardonActing Chief Financial Officer | 30,000 | — | — | 30,000 | — | |
| Dec 6, 2018 AForm 4 → | Dec 7, 5:34 pm EST | Joseph LevequeChief Medical Officer | 117,000 | — | — | 117,000 | — | |
| Dec 6, 2018 AForm 4 → | Dec 7, 5:32 pm EST | Marcos MillaChief Scientific Officer | 125,000 | — | — | 125,000 | — | |
| Dec 6, 2018 AForm 4 → | Dec 7, 5:30 pm EST | Laura ShawverPresident and CEO, Director | 506,000 | — | — | 506,000 | — | |
| Dec 6, 2018 AForm 4 → | Dec 7, 5:30 pm EST | Peter KolchinskyDirector, 10% Owner | 30,000 | — | — | 30,000 | — |